<![CDATA[Ofatumumab studie 61:]]>Ofatumumab studie 61:
Ofatumumab and Bortezomib in Subjects With Relapsed CD20+ NHL
This study is not yet open for participant recruitment.
Verified on July 2011 by OHSU Knight Cancer Institute

First Received on July 13, 2011. Last Updated on July 18, 2011 History of Changes
Sponsor: OHSU Knight Cancer Institute
Collaborator: National Cancer Institute (NCI)

Information provided by: OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier: NCT01397591

]]>https://dev.proinvestor.com/forum/topic/448365/ofatumumab-studie-61RSS for NodeSat, 20 Jun 2026 08:32:06 GMTTue, 19 Jul 2011 16:08:54 GMT60